| Document |
Document Title |
|
WO/2015/127956A1 |
The present invention relates to a process for obtaining Tiacumicin B with a well defined crystal habit and particle size. The process according to the invention comprises repeating cycles of heating and cooling under controlled conditio...
|
|
WO/2015/124114A1 |
Disclosed are a phenolic hydroxyl flavone compound semisynthesis method and iodine recovery method, relating to approaches A and B and iodine recovery. In approach A, flavone is dissolved in a pyridine solvent of ethylene glycol or glyce...
|
|
WO/2015/124113A1 |
Provided is a semi-synthesis method for luteolin, galuteolin and luteolin rutinoside. In the method, two steps of dehydrogenation and demethylation are combined into one step, and reaction conditions of dehydrogenation and demethylation ...
|
|
WO/2015/125782A1 |
A method for producing a compound represented by general formula (II) via a step for reacting a compound represented by general formula (I) with a sulfur compound, and a compound. In general formulas (I) and (II), R1 represents a hydroge...
|
|
WO/2015/122428A1 |
[Problem] To provide a method for producing an organic compound whereby a reaction between substances can be promoted. [Solution] A method for producing an organic compound comprising: a mixing step for mixing a first liquid with a secon...
|
|
WO/2015/119767A1 |
A process is described for improving the performance of certain multiphase reaction systems including a solid catalyst, one or more reactants in the gas phase and one or more reactants in the liquid phase, wherein a targeted maximum conc...
|
|
WO/2015/113370A1 |
Disclosed is a stevioside A glycoside crystal form 7, the structure whereof is represented by the formula I. The X-ray powder diffraction (XRPD) figure of the crystal form 7 has the following characteristic peaks at the angles of 2θ±0....
|
|
WO/2015/113369A1 |
Disclosed is a stevioside A glycoside crystal form 9, of which the structure is represented by the formula I. The X-ray powder derivative (XRPD) figure of the crystal form 9 has the following characteristic peaks at the angles of 2θ±0....
|
|
WO/2015/111086A1 |
The present invention discloses one pot process for the conversion of hemicellulose into C5 sugars using ionic liquids in water media.
|
|
WO/2015/106943A1 |
The present application discloses a simple process for the purification of neutral human milk oligosaccharides (HMOs) produced by microbial fermentation. The process uses a combination of a cationic ion exchanger treatment, an anionic io...
|
|
WO/2015/101183A1 |
The invention relates to uracil nucleotide analogs, preparation methods therefor and uses thereof. Specifically, the invention provides uracil nucleotide analogic compounds having the following formula (I), stereoisomers or pharmaceutica...
|
|
WO/2015/101916A1 |
An improved process for the preparation of empagliflozin is disclosed. Novel intermediates of formulas (13) and (14) for the preparation of empagliflozin are also disclosed, wherein R1 and R2 are independently hydrogen or hydroxyl protec...
|
|
WO/2015/102018A1 |
This invention relates to Chlorophytum borivilianum, popularly known as Safed Musli. Currently, the active nutrition enhancing ingredients such as Stigmasterol and Hecogenin are extracted from the tuber of the product which is available ...
|
|
WO/2015/097445A1 |
The present invention provides a method comprising: (i) contacting a cellulose-comprising input material with an aqueous hydrolyzing solution comprising at least 35%wt. of at least one mineral acid to form a hydrolyzate comprising a mixt...
|
|
WO/2015/092374A1 |
There is provided a method for the chlorination of a sucrose-6-acylate to produce a 4,1',6'-trichloro-4,1',6'-trideoxy-galactosucrose-6-acylate,
wherein said method comprises the following steps (i) to (v): (i) providing a first compone...
|
|
WO/2015/095399A1 |
Described is a method of processing biomass to separate it into a liquid fraction enriched in solubilized C5 -sugar-containing oligomers and C-5 sugar monomers and a solid fraction enriched in substantially insoluble cellulose and C6-sug...
|
|
WO/2015/081778A1 |
The present invention belongs to the field of organic synthesis, relates to a method for synthesizing a saponin, and in particular, to a method for constructing a glycosidic bond in a saponin, and comprises the following steps: directly ...
|
|
WO/2015/084075A1 |
The present invention provides a cucurbituril-sugar conjugate and a method for preparing the same, wherein cucurbituril recognizes sugar to support and stabilize the sugar in a cucurbituril cavity.
|
|
WO/2015/081867A1 |
The present invention provides a gemcitabine derivative of formula (I) and a method for preparing the same. The present invention further relates to a pharmaceutical composition comprising a pharmaceutically effective dose of the gemcita...
|
|
WO/2015/070571A1 |
The present invention relates to a disaccharide intermediate and a synthesis method thereof, relates to the chemical pharmaceutical field, and more specifically relates to a method for preparing a disaccharide segment of a key intermedia...
|
|
WO/2015/067640A1 |
The invention relates to an efficient and reproducible process for generating glucosamine from plants which allows high glucosamine content to be obtained while reducing the content of residual ammonium or sulfate ions. The invention als...
|
|
WO/2015/054465A1 |
Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Picornavirus and/or Flaviviridae infection with one or more nucleosides, ...
|
|
WO/2015/050881A1 |
Various systems and methods are provided for converting lignocellulosic biomass (102) to concentrated sugars (104). For example, a saccharification process includes obtaining lignocellulosic biomass (102) and converting the lignocellulos...
|
|
WO/2015/043511A1 |
Disclosed are glucopyranosyl derivatives used as sodium dependent glucose cotransporters (SGLTs) inhibitors, intermediates or preparation processes thereof, and pharmaceutical uses thereof, especially glucopyranosyl derivatives represent...
|
|
WO/2015/043493A1 |
The present invention relates to a 5-formylcytosine specific chemical labeling method and related applications in aspects such as sequencing, detection, imaging, and diagnosis. In the method, a condensation reaction occurs between an act...
|
|
WO/2015/036138A1 |
The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host mic...
|
|
WO/2006/111802A9 |
Process for the preparation of trivalent iron complexes with mono-, di- and polysaccharide sugars, consisting of the activation of the sugar by oxidation with nascent bromine generated in situ by reaction be tween an alkaline or alkaline...
|
|
WO/2015/014959A1 |
The present invention relates a process for the recovery of one or more steviol glycosides from a steviol glycoside-containing fermentation broth, which method comprises (a) providing a fermentation broth comprising one or more steviol g...
|
|
WO/2015/011519A1 |
The present invention provides improved processes of preparing Fondaparinux sodium comprising converting a compound of formula ABCDE4 to Fondaparinux sodium at a reaction pH of no more than about 9.0. In some embodiments, the intermediat...
|
|
WO/2015/011517A1 |
The present invention provides novel processes for the preparation of Fondaparinux sodium by using the compound of formula ABC5. In some embodiments, the intermediates for the synthesis of Fondaparinux sodium, are also provided.
|
|
WO/2015/009145A1 |
The present invention is directed at a process for fractionating lignocellulosic biomass for the purpose of reducing processing costs, increasing delignification, reducing side- reactions, in particular reducing hemicelluloses degradatio...
|
|
WO/2015/002954A1 |
The present invention provides synthetic Pseudomonas aeruginosa lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various P. aeruginosa serotype-specific oligosaccharide antigens or various core P. aeruginosa oli...
|
|
WO/2014/206299A1 |
Disclosed in the present invention is a method for preparing a liflozin drug intermediate using a microreactor, comprising: mixing compound III dissolved in an organic solvent with an organometallic reagent in a microreactor unit (L) by ...
|
|
WO/2014/210564A1 |
Described herein are synthetic glycan conjugates comprising a carrier and a glycan moiety derived from Neisseria meningitidis, wherein the glycan moiety is covalently linked to the carrier through a linker. Also provided herein are a mix...
|
|
WO/2014/204104A1 |
Provided are a method of producing a compound in which a sugar of a glycoside is reduced or removed, and an extract, a pharmaceutical composition, and a food composition including the compound.
|
|
WO/2014/194826A1 |
The present invention provides a three-circle fused-heterocycle nucleoside phosphoramidate compound, a preparation method therefor, a composition containing the fused-heterocycle nucleoside phosphoramidate compound, and an application of...
|
|
WO/2014/196861A1 |
A fructoside-containing product is manufactured from a glucose-rich feedstock, in a process wherein glucose to fructose is isomerized by contacting the glucose-rich feedstock with a basic isomerization catalyst in an alcoholic medium at ...
|
|
WO/2014/193934A1 |
Methods of preparing highly purified steviol glycosides, particularly rebaudiosides A, D and M are described. The methods include utilizing recombinant microorganisms for converting various staring compositions to target steviol glycosid...
|
|
WO/2014/193888A1 |
Methods of preparing highly purified steviol glycosides, particularly rebaudiosides A, D and M are described. The methods include utilizing recombinant microorganisms for converting various staring compositions to target steviol glycosid...
|
|
WO/2014/189163A1 |
The present invention relates to a method for producing galactose from whey permeate liquid or whey permeate powder solution, the method comprising: a step of removing a solid precipitate from the whey permeate liquid or the solution of ...
|
|
WO/2014/190024A1 |
The invention concerns compounds of the formula (I) wherein: Y1 and Y2 are independently a monosaccharide or disaccharide; X1 and X2 are independently -(R9-O)m-, -(R10)P-, -O-(R11-O)q-, -R16-O-R17-O- or a covalent bond; Q1 and Q2 are ind...
|
|
WO/2014/187364A1 |
The present invention relates to a preparation method of trihydroxyethyl rutoside. In the method, rutin is firstly prepared into 7-monohydroxyethyl rutoside in a content of greater than or equal to 98% by weight, and then 7-monohydroxyet...
|
|
WO/2014/187365A1 |
The present invention relates to a oxabicyclo derivative, preparation method and use thereof, specifically to oxabicyclo derivatives shown by general formula (I) or hydrates, solvates, stereoisomers thereof, pharmaceutically acceptable s...
|
|
WO/2014/183630A1 |
The present invention provides a compound as represented by formula I, which has a structure as follows: R1 and R2 are glycosyl, R3 is H, hydroxyl or methoxyl; R4 is hydroxyl or methoxyl; and R5 is H, hydroxyl or methoxyl. The present in...
|
|
WO/2014/180264A1 |
The invention relates to a stable organic amine salt of fosphenytoin and the preparation method and use thereof, the related organic amine salt of fosphenytoin having a structure of the general formula as shown in general formula (I), an...
|
|
WO/2014/177119A1 |
A new polymorph of 2-[4-[(methylamino)carbonyl]-1 H-pyrazol-1- yl]adenosine (designated as polymorph E), of formula I, characterized by an X-ray diffraction pattern of X-RPD showing the following reflections at 2 Theta = 5.8°, 12.3°, 1...
|
|
WO/2014/167537A1 |
This invention relates to a chemo-enzymatic synthesis of oligosaccharidesof formula 1 wherein R is selected from -OH, -N3 and -OR6 wherein R6 is selected from allyl optionally substituted by one or more methyl, propargyl optionally subst...
|
|
WO/2014/167538A1 |
This invention relates to achemo-enzymatic synthesis of oligosaccharides of formula 1 I wherein R is selected from -OH, -N 3 and -OR 6 wherein R 6 is selected from allyl optionally substituted by one or more methyl, propargyl optionally ...
|
|
WO/2014/166139A1 |
The present invention relates to a method for synthesizing dibekacin and arbekacin. The method comprises: using kanamycin B as an initial raw material, protecting five amino groups of the kanamycin B by using t-butyloxycarboryl, protecti...
|
|
WO/2014/164557A1 |
The present invention provides methods for producing monomeric and oligomeric carbohydrate from solids biomass using a pressurized reaction vessel. In particular, methods of the invention utilize solvent and acid hydrolysis in continuous...
|
